Biotech Specialty Pharma

Stellar Pharmaceuticals

544 Egerton St.
London, ON N5W 3Z8 UK
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Therapeutic products for selected markets

Management Peter Riehl, President; Janice Clarke, Director of Administration, CFO; David Butts, Director of Commercial Operations; Paul MacPherson, Director of Operations; Peter Brownrigg, Director of Sales and Marketing

Click here for Financial Data
Keywords: osteoarthritis, hyaluronate, proteoglycan, neoVisc, anaesthetic, Orthopedics, Rheumatology, joint, joints


Updated: Aug. 24, 2014


Ontario based Stellar Pharmaceuticals Inc. develops and markets therapeutic products for selected healthcare markets. The company commenced operations in 1996 with its development strategy focused on ......view more

Products / Services

NeoVisc is a 1.0% solution of highly purified Sodium Hyaluronate A Natural Viscosupplement For The Treatment of Osteoarthritis Uracyst is an effective treatment for interstitial cystitis. Skelite, Syn......view more

Technology / Differentiation

NeoVisc works as a viscosupplement by improving the natural viscosity and elasticity of synovial fluid, thereby increasing lubrication, improved joint mobility and a reduction of pain. The active i...view more

Market / Customers

Interstitial Cystitis (IC) is an inflammatory disease of the bladder wall.......view more